Priyadharsini Nagarajan

Author

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Doina Ivan, Jonathan Curry, P Nagarajan, P. Nagarajan, Priyadharsini Nagarajan, Priyadharsini Nagarajan (267957), Priyardhisini Nagarajan

296

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center University at Buffalo, State University of New York Baylor College of Medicine

About

Priyadharsini Nagarajan is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	26	853
2	Cell Biology	6	6	190
3	Health Sciences	2	2	26
4	Natural Sciences	1	1	22
5	Biochemistry	1	1	22

Priyadharsini Nagarajan

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients Michael T. Tetzlaff, Kelly C. Nelson, Adi Diab, Journal for ImmunoTherapy of Cancer	2018	150
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, Clinical Cancer Research	2021	132
Autoimmune dermatologic toxicities from immune checkpoint blockade with anti‐<scp>PD</scp>‐1 antibody therapy: a report on bullous skin eruptions George Jour, Isabella C. Glitza, Rachel M. Ellis, Journal of Cutaneous Pathology ImmunologyPathologyBullous Skin EruptionsDermatologyImmune Checkpoint Blockade	2016	130
Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features Michael T. Tetzlaff, Priyadharsini Nagarajan, Susan Y. Chon, American Journal of Dermatopathology	2017	110
Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma Laurence Feldmeyer, Courtney W. Hudgens, Genevieve Ray-Lyons, Clinical Cancer Research	2016	106
Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance Phyu P. Aung, Priyadharsini Nagarajan, Víctor G. Prieto Laboratory Investigation Dermoscopic ImageMelanomaPathologyPrimary Cutaneous MelanomaDermatology	2017	98
Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm Narittee Sukswai, Phyu P. Aung, C. Cameron Yin, The American Journal of Surgical Pathology ImmunologyImmunoeditingPathologyImmunophenotypingImmunologic Mechanism	2019	81
Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors Ayse Selen Yilmaz, Hatice Gülçin Özer, Jessica L. Gillespie, Cancer	2016	80
Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Samantha Tam, Christopher M. K. L. Yao, Moran Amit, JAMA Otolaryngology–Head & Neck Surgery	2019	73
Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell Lymphomas Eric Dean Merrill, Rose Lou Marie C. Agbay, Roberto N. Miranda, The American Journal of Surgical Pathology	2016	69

Page 1